Electrophoresis Market

Electrophoresis Market Research, 2031

The global electrophoresis market size was $2.3 billion in 2021, and is projected to reach $4 billion by 2031, growing at a CAGR of 5.7% from 2022 to 2031. Electrophoresis is a technique used for separation of proteins and nucleic acids. Electrophoresis equipment and supplies are primarily used for RNA and DNA analysis. It is also used in biochemistry for separation of molecules based on size, affinity, or charge. The separation of proteins based on size, purity, and density is carried out using electrophoresis. The simplicity in using this technique enables its use in various applications, such as diagnosis of hemoglobinopathies, vaccine analysis, antibody analysis, and drug quality control. Increase in use of next-generation sequencing, industry-academic collaborations, and increasing government funding for research on electrophoresis boosts the global electrophoresis market size. However, time consuming operation and availability of alternative technologies hinder the growth of the market. On the other hand, increase in demand for personalized medicine and focus on proteomics research is expected to create opportunities in the market.

The COVID-19 pandemic has positively impacted the electrophoresis market. Capillary electrophoresis separates molecular components of a sample used for examination on the basis of mass, charge, and nucleic acid chain length. Electrophoresis was widely used during pandemic for research purpose. Various types of research activities were conducted to study viral particles.

An increase in the number of research activities in biochemistry and medical research projects are some of the prime factors responsible for the growth of the electrophoresis devices market at the global level. Increase in complexities in the treatment of diseases, such as cancer, genetic transmitted diseases and other health issues, is also one of the major factors fueling the growth of the electrophoresis market. The application of electrophoresis devices in areas, such as microbial detection and protein analysis, is boosting the popularity of electrophoresis devices.

Moreover, recent advances in electrophoresis systems are now providing electrophoresis market opportunity to target new applications. There has been a development of a wide array of new technologies ranging from PerkinElmer’s microfluidic electrophoresis platforms to polyacrylamide gel electrophoresis as well as SDS PAGE and 2D gel electrophoresis. Many of these technologies have yielded highly promising results. Moreover, there has been a significant increase in spending for the development of electrophoresis technology.

The electrophoresis market is segmented into Product, Application and End User. On the basis of product, the market is divided into electrophoresis reagents, electrophoresis systems, and gel documentation systems and software. Electrophoresis reagents is further divided into protein electrophoresis reagents, and nucleic acid electrophoresis reagents. Electrophoresis systems is further categorized into gel electrophoresis systems, and capillary electrophoresis systems. By application, it is divided into diagnostics, research, and quality control and process validation. By end user, it is categorized into academic research institutes, hospitals and diagnostic centers, pharmaceutical and biotechnology companies, and research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By product, the electrophoresis reagents segment currently dominates the global electrophoresis market share and is expected to continue during the forecast period, owing to increase in funding for genomic and proteomic research, rise in prevalence of chronic diseases, surge in collaborations between industry and academics, and technological developments.

By application, the research segment dominated the market in 2021, and this trend is expected to continue during the forecast period owing to increasing application of electrophoresis in the field of drug discovery, proteomics, genomics, and antibody research. However, the quality control and process validation segment is expected to witness considerable growth during the electrophoresis market forecast period due to improvement in the sensitivity, precision, and speed of the electrophoresis equipment. Also, factors such as rising demand for innovative therapies and drugs and an increase in demand and interest in research associated with DNA, genes, and proteins are expected to propel the growth of the market in the forecast period.

By end user, the pharmaceutical and biotechnology companies segment dominated the market in 2021, and this trend is expected to continue during the forecast period owing to rise in penetration of electrophoresis in pharmaceutical & biotechnology companies, for DNA analysis, testing of antibodies, protein detection, and DNA fragmentation. However, the research institutes segment is expected to witness considerable growth during the forecast period due to increase in adoption of electrophoresis offer significant advantages for research organizations such as it is less time consuming, has less requirement of reagents, and minimal quantity of sample is required.

Region wise, North America dominated the market in 2021, owing to increase in government funds for detection of new proteins, rise in R&D activities of new drugs for diagnosis and treatment options, as well as surge in prevalence of chronic diseases such as cancer and diabetes. However, Asia-Pacific is expected to witness considerable electrophoresis market growth during the forecast period due to increase in per capita income in many countries, rise in government initiatives for improvement of the healthcare sector, and surge in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries are fueling the growth of the market in this region.

The major companies profiled in the electrophoresis industry report include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Merck Group, Agilent Technologies, Inc., Danaher Corporation, Lonza Group, PerkinElmer Inc., QIAGEN N.V., Harvard Bioscience, Inc., and Shimadzu Corporation.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the electrophoresis market analysis from 2021 to 2031 to identify the prevailing electrophoresis market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the electrophoresis market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global electrophoresis market trends, key players, market segments, application areas, and market growth strategies.

 Electrophoresis Market Report Highlights